# STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)

> **NCT02306577** · — · UNKNOWN · sponsor: **Vancouver Infectious Diseases Centre** · enrollment: 30 (estimated)

## Conditions studied

- HIV
- Illicit Drug User

## Interventions

- **DRUG:** STRIBILD

## Key facts

- **NCT ID:** NCT02306577
- **Lead sponsor:** Vancouver Infectious Diseases Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-04
- **Final completion:** 2016-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306577, "STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02306577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*